Verrica Pharmaceuticals once again resubmits new drug application for skin disease treatment

Two previous applications were turned down, but the effectiveness of the treatment has never been questioned.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.